Shanghai Shyndec Pharmaceutical Co Ltd (600420) — Financial Flexibility Index
Shanghai Shyndec Pharmaceutical Co Ltd (600420) has a Financial Flexibility Index of 0.15x as of September 2025. Free cash flow of CN¥553.14 Million (operating CF CN¥486.04 Million minus capex CN¥67.11 Million) represents 0% of total liabilities (CN¥3.63 Billion). Check Shanghai Shyndec Pharmaceutical Co Ltd (600420) strategic asset index to assess the company's strategic physical and investment asset allocation.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Shanghai Shyndec Pharmaceutical Co Ltd Financial Flexibility Index (2004–2024)
Historical Financial Flexibility Index trend for Shanghai Shyndec Pharmaceutical Co Ltd across 21 annual periods. See 600420 working capital ratio to evaluate short-term liquidity relative to the company's equity base.
Annual Financial Flexibility Index for Shanghai Shyndec Pharmaceutical Co Ltd (2004–2024)
Year-by-year free cash flow to debt coverage for Shanghai Shyndec Pharmaceutical Co Ltd. For the full company profile including market capitalisation, see market cap of Shanghai Shyndec Pharmaceutical Co Ltd.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2024 | 0.53x | CN¥2.48 Billion | CN¥2.26 Billion | CN¥4.63 Billion | ▲ +28.9% |
| 2023 | 0.41x | CN¥2.08 Billion | CN¥1.72 Billion | CN¥5.01 Billion | ▼ -2.0% |
| 2022 | 0.42x | CN¥3.16 Billion | CN¥2.86 Billion | CN¥7.48 Billion | ▲ +67.2% |
| 2021 | 0.25x | CN¥2.20 Billion | CN¥1.68 Billion | CN¥8.70 Billion | ▲ +10.1% |
| 2020 | 0.23x | CN¥1.94 Billion | CN¥1.56 Billion | CN¥8.43 Billion | ▲ +15.8% |
| 2019 | 0.20x | CN¥1.67 Billion | CN¥1.27 Billion | CN¥8.44 Billion | ▼ -23.1% |
| 2018 | 0.26x | CN¥2.07 Billion | CN¥1.67 Billion | CN¥8.02 Billion | ▼ -21.9% |
| 2017 | 0.33x | CN¥2.48 Billion | CN¥2.31 Billion | CN¥7.52 Billion | ▲ +146.9% |
| 2016 | 0.13x | CN¥1.08 Billion | CN¥838.58 Million | CN¥8.08 Billion | ▼ -26.8% |
| 2015 | 0.18x | CN¥461.17 Million | CN¥226.65 Million | CN¥2.53 Billion | ▼ -36.0% |
| 2014 | 0.29x | CN¥689.05 Million | CN¥258.51 Million | CN¥2.42 Billion | ▼ -27.9% |
| 2013 | 0.40x | CN¥720.12 Million | CN¥207.50 Million | CN¥1.82 Billion | ▼ -15.6% |
| 2012 | 0.47x | CN¥598.94 Million | CN¥193.41 Million | CN¥1.28 Billion | ▼ -3.5% |
| 2011 | 0.49x | CN¥264.52 Million | CN¥136.12 Million | CN¥544.70 Million | ▼ -46.6% |
| 2010 | 0.91x | CN¥271.12 Million | CN¥115.11 Million | CN¥298.05 Million | ▲ +51.4% |
| 2009 | 0.60x | CN¥128.73 Million | CN¥97.43 Million | CN¥214.24 Million | ▲ +37.1% |
| 2008 | 0.44x | CN¥71.60 Million | CN¥58.04 Million | CN¥163.41 Million | ▼ -55.1% |
| 2007 | 0.98x | CN¥116.76 Million | CN¥82.31 Million | CN¥119.57 Million | ▼ -38.0% |
| 2006 | 1.57x | CN¥135.59 Million | CN¥73.60 Million | CN¥86.15 Million | ▲ +29.6% |
| 2005 | 1.21x | CN¥129.55 Million | CN¥57.90 Million | CN¥106.67 Million | ▲ +175.1% |
| 2004 | 0.44x | CN¥32.81 Million | CN¥17.02 Million | CN¥74.32 Million | — |